Treatment of acne vulgaris

被引:167
作者
Haider, A [1 ]
Shaw, JC [1 ]
机构
[1] Univ Toronto, Div Dermatol, Toronto, ON, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 06期
关键词
D O I
10.1001/jama.292.6.726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Management of acne vulgaris by nondermatologists is increasing. Current understanding of the different presentations of acne allows for individualized treatments and improved outcomes. Objective To review the best evidence available for individualized treatment of acne. Data Sources Search of MEDLINE, EMBASE, and the Cochrane database to search for all English-language articles on acne treatment from 1966 to 2004. Study Selection Well-designed randomized controlled trials, meta-analyses, and other systematic reviews are the focus of this article. Data Extraction Acne literature is characterized by a lack of standardization with respect to outcome measures and methods used to grade disease severity. Data Synthesis Main outcome measures of 29 randomized double-blind trials that were evaluated included reductions in inflammatory, noninflammatory, and total acne lesion counts. Topical retinoids reduce the number of comedones and inflammatory lesions in the range of 40% to 70%. These agents are the mainstay of therapy in patients with comedones only. Other agents, including topical antimicrobials, oral antibiotics, hormonal therapy (in women), and isotretinoin all yield high response rates. Patients with mild to moderate severity inflammatory acne with papules and pustules should be treated with topical antibiotics combined with retinoids. Oral antibiotics are first-line therapy in patients with moderate to severe inflammatory acne while oral isotretinoin is indicated for severe nodular acne, treatment failures, scarring, frequent relapses, or in cases of severe psychological distress. Long-term topical or oral antibiotic therapy should be avoided when feasible to minimize occurrence of bacterial resistance. Isotretinoin is a powerful teratogen mandating strict precautions for use among women of childbearing age. Conclusions Acne responses to treatment vary considerably. Frequently more than 1 treatment modality is used concomitantly. Best results are seen when treatments are individualized on the basis of clinical presentation.
引用
收藏
页码:726 / 735
页数:10
相关论文
共 100 条
[11]   Systematic review of Propionibacterium acnes resistance to systemic antibiotics [J].
Cooper, AJ .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (05) :259-261
[12]   Acne vulgaris - A disease of western civilization [J].
Cordain, L ;
Lindeberg, S ;
Hurtado, M ;
Hill, K ;
Eaton, SB ;
Brand-Miller, J .
ARCHIVES OF DERMATOLOGY, 2002, 138 (12) :1584-1590
[13]   Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle [J].
Cunliffe, WJ ;
Meynadier, J ;
Alirezai, M ;
George, SA ;
Coutts, I ;
Roseeuw, DI ;
Hachem, JP ;
Briantais, P ;
Sidou, F ;
Soto, P .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (03) :S218-S226
[14]  
Cunliffe WJ, 2002, EUR J DERMATOL, V12, P350
[15]   A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris [J].
Cunliffe, WJ ;
Holland, KT ;
Bojar, R ;
Levy, SF .
CLINICAL THERAPEUTICS, 2002, 24 (07) :1117-1133
[16]  
Cunliffe WJ, 1998, BRIT J DERMATOL, V139, P48
[17]  
CUSAN L, 1994, FERTIL STERIL, V61, P281
[18]   TOPICAL ERYTHROMYCIN SOLUTION IN ACNE - RESULTS OF A MULTICLINIC TRIAL [J].
DOBSON, RL ;
BELKNAP, BS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1980, 3 (05) :478-482
[19]   Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris [J].
Dreno, B ;
Moyse, D ;
Alirezai, M ;
Amblard, P ;
Auffret, N ;
Beylot, C ;
Bodokh, I ;
Chivot, M ;
Daniel, F ;
Humbert, P ;
Meynadier, J ;
Poli, F .
DERMATOLOGY, 2001, 203 (02) :135-140
[20]   Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne, patients and prescribers [J].
Eady, AE ;
Cove, JH ;
Layton, AM .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (12) :813-831